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Comment to Management of exacerbations
of chronic obstructive pulmonary disease with
a focus on comorbidities by Jadwiga A.
Wedzicha
The term exacerbation of chronic obstructive pul-
monary disease (ECOPD) identifies the acute phase
of COPD, i.e. the presentation of symptoms due to the
worsening of the characteristic chronic airway and/or
pulmonary inflammation associated with the disease.1
Events that fall within the term ECOPD are, for ex-
ample, viral or bacterial respiratory infections during
which the inflammatory process triggered by the in-
fection overlaps with the chronic inflammation and re-
sults in a worsening of the typical symptoms of
COPD, i.e. dyspnea, cough, and sputum. Mechanisms
are stimulation of nerve reflexes, bronchial and vas-
cular congestion, purulent secretions, bronchocon-
striction, and alteration of the ventilation/perfusion in-
teraction in the lung.2
In a short but concise and comprehensive review on
ECOPD published in this issue of the Journal,3 Prof.
Wedzicha, one of the most influent experts on COPD,
describes the complexity not only of the ECOPD but
also of the COPD patient. In fact, the COPD patient
often suffers from concomitant chronic diseases, both
respiratory (e.g. asthma, bronchiectasis, pulmonary fi-
brosis, etc.) and non-respiratory (hypertension, heart
failure, ischemic heart disease, arrhythmia, gastro-
esophageal reflux, obesity, dyslipidemia, arteriosclero-
sis, osteoporosis, diabetes, depression, etc.).
Patients with COPD and concomitant chronic dis-
eases are often elderly and frail, and are frequently at
higher risk both of acute newly developed episodes
(bronchitis, pneumonia, pulmonary embolism, pneu-
mothorax, etc.) and of worsening of concomitant
chronic disease (e.g. asthma and/or bronchiectasis ex-
acerbation, hypertension, heart failure, myocardial is-
chemia, heart infarction, etc.).4 Prof. Wedzicha
recommends that physicians and medical staff should
always consider these complex issues when visiting
and treating patients with ECOPD. A useful example
that emphasizes the importance of this comprehensive
approach comes from a recent study of the Federation
of Associations of Hospital Doctors on Internal Med-
icine (FADOI) conducted in emergency units located
in Lombardy, northern Italy, and reported in our Jour-
nal.5 This study showed that, in COPD patients com-
ing to the emergency unit with worsening dyspnea, the
cause was primarily due to heart failure, not to acute
bronchitis.5
The conclusions of Prof. Wedzicha’s review are
both novel and of importance: i) in most cases,
ECOPD may not be just an exacerbation of COPD,
but the result of the complex interaction between res-
piratory and non-respiratory mechanisms; ii) consid-
ering this complexity, the expression ECOPD seems
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ABSTRACT
Exacerbation of chronic obstructive pulmonary disease (ECOPD) identifies the acute phase of COPD. The COPD patient is
often frail and elderly with concomitant chronic diseases. This requires the physician not only looks at specific symptoms or
organs, but to consider the patient in all his or her complexity.
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to be more and more restrictive, and a new terminol-
ogy that also reflects complexity and severity should
be developed; iii) the complexity of the involved
mechanism leads us to believe that the treatment for
ECOPD recommended by current guidelines1 (bron-
chodilators, steroids, antibiotics) only focuses on re-
lieving respiratory symptoms. It seems that treatment
is very limited and probably only marginally effective,
and that a more comprehensive treatment should
be provided to address potential concomitant non-
respiratory components (e.g. heart failure, throm-
boembolisms, etc.).
COPD exacerbations that lead to hospitalization
have a poor prognosisis,6 with 28% risk of death in
one year and 80% in nine years.7,8 The most frequent
causes of death in patients with ECOPD are pul-
monary embolism, heart failure, respiratory infections
and respiratory failure.9,10
It is possible that, as happened in patients with my-
ocardial infarction, a new comprehensive pharmaco-
logical and non-pharmacological treatment and its
early application might improve the prognosis of
ECOPD. This would only be possible if we not only
look at specific symptoms or organs, but consider the
patient in all his or her complexity.
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